A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Trichlormethiazide
Imidapril
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Imidapril.
Trichlormethiazide
Enalaprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Enalaprilat.
Trichlormethiazide
Temocapril
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Temocapril.
Trichlormethiazide
Rescinnamine
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Rescinnamine.
Trichlormethiazide
Candesartan
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Oxyphenbutazone.
Trichlormethiazide
Fimasartan
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Oxyphenbutazone.
Trichlormethiazide
Azilsartan medoxomil
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Oxyphenbutazone.
Trichlormethiazide
Saralasin
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saralasin is combined with Oxyphenbutazone.
Trichlormethiazide
Tasosartan
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tasosartan is combined with Oxyphenbutazone.
Trichlormethiazide
Saprisartan
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saprisartan is combined with Oxyphenbutazone.
Trichlormethiazide
Forasartan
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Oxyphenbutazone.
Trichlormethiazide
Irbesartan
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Irbesartan is combined with Oxyphenbutazone.
Trichlormethiazide
Troxerutin
The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Troxerutin.
Trichlormethiazide
Reviparin
The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Reviparin.
Trichlormethiazide
Dabigatran
The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Dabigatran.
Trichlormethiazide
Edetate calcium disodium anhydrous
The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Edetate calcium disodium anhydrous.
Trichlormethiazide
Tocopherylquinone
The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Tocopherylquinone.
Trichlormethiazide
(S)-Warfarin
The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with (S)-Warfarin.
Trichlormethiazide
Saruplase
The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Saruplase.
Trichlormethiazide
Melagatran
The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Melagatran.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3